VivoSeq
Infectious Disease

Fungal Infection

2

Pipeline Programs↗

1

Active Trials↗

8

Companies Involved↗

Fungal Infection is an early-stage landscape with 2 programs across 8 companies. The most active players are Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Prism Pharmaceuticals, Pfizer.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

50/100

Completion Rate

87/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

1 program

Phase 1P

Prism Pharmaceuticals

1 program

Phase 1Pfizer logo

Pfizer

0 programs

PreclinicalAstellas logo

Astellas

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalBayer logo

Bayer

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 12

Doxycycline

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Voriconazole

Prism Pharmaceuticals

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

33

clinical trials

Completed27 · 82%
Terminated3 · 9%
Withdrawn1 · 3%
Unknown status1 · 3%
Recruiting1 · 3%

Clinical Trials

Trial Activity

33 trials

Studies of Disorders With Increased Susceptibility to Fungal Infections
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT01222741·850 enrolled
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
Completed·Pfizer logoPfizer·Phase 3·NCT00002277
A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00001065·70 enrolled
A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
Completed·Pfizer logoPfizer·N/A·NCT00002282
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
Completed·Pfizer logoPfizer·N/A·NCT00002325
Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
Completed·Astellas logoAstellas·N/A·NCT03174457·120 enrolled
Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy Participants
Completed·Bayer logoBayer·Phase 3·NCT04532164·137 enrolled
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00000676·500 enrolled
Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Completed·Astellas logoAstellas·Phase 1·NCT00607763·9 enrolled
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection
Completed·Pfizer logoPfizer·Phase 2·NCT00739934·40 enrolled
To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early
Completed·SSingapore General Hospital·Phase 3·NCT00361517·47 enrolled
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
Completed·Pfizer logoPfizer·N/A·NCT00002304
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
Completed·Merck & Co. logoMerck & Co.·Phase 3·NCT00250432·204 enrolled
Trained Immunity in Fungal Infection and Its Mechanism
Completed·ZZhongnan Hospital·Phase 1·NCT06628544·79 enrolled
A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole
Completed·Johnson & Johnson logoJohnson & Johnson·N/A·NCT00002341
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)